Adline Chem Lab Limited

KAMRLAB

INE276T01018

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 06:00:56 2024-06-28 EDT			5-day change	1st Jan Change
13.12 ^INR	+4.96%		-0.98%	-51.03%

03-05	Adline Chem Lab CFO Steps Down	MT
03-05	Adline Chem Lab Limited Announces CFO Changes	CI

Kamron Laboratories Ltd Appoints Devarshi D. Patel as an Independent Director of the Company

September 07, 2015

Kamron Laboratories Ltd. announced that Mr. Devarshi D. Patel has been appointed as an Independent Director of the company with effect from March 30, 2015.

Latest news about Adline Chem Lab Limited

Adline Chem Lab CFO Steps Down	03-05	MT
Adline Chem Lab Limited Announces CFO Changes	03-05	CI
Adline Chem Lab Limited Appoints Sarang Pathak as Managing Director	03-05	CI
Adline Chem Lab Limited Announces Resignation of Kamlesh Lashkari as Director	02-28	CI
Adline Chem Lab Appoints CFO	02-04	MT
Adline Chem Lab Limited Announces Management Changes	02-03	CI
Adline Chem Lab Limited Announces Chief Financial Officer Changes	02-03	CI
Adline Chem Lab Limited Announces Change of Registered Office Address	02-03	CI
Adline Chem Lab Limited Announces Resignation of Ms. Bhavasthi Mehta as Company Secretary and Compliance Officer	23-07-31	CI
Hemant Amrish Parikh entered into a share purchase agreement to acquire a 24.48% in Adline Chem Lab Limited from Kamlesh J. Laskari HUF, Ranak K. Laskari, Rohan K. Laskari and Sohan K. Laskari for INR 7.5 million.	23-05-17	CI
Hemant Amrish Parikh made an open offer to acquire a 26% stake in Adline Chem Lab Limited for INR 8 million.	23-05-17	CI
Kamron Laboratories : Changes Company Name to Adline Chem Lab	21-10-14	MT
Kamron Laboratories : Changes Name to Adline Chem Lab	21-10-14	MT
Kamron Laboratories Limited has Changed its Name to ADLINE CHEM LAB LIMITED	21-09-30	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2021	21-08-14	CI
Kamron Laboratories Ltd Reports Audited Standalone Earnings Results for the Fourth Quarter and Year Ended March 31, 2021	21-06-30	CI
Kamron Laboratories Ltd Announces Board Changes	21-04-09	CI
Kamron Laboratories Ltd Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2020	21-02-13	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2020	20-09-22	CI
Kamron Laboratories Ltd Announces Earnings Results for the Year Ended March 31, 2020	20-08-31	CI
Kamron Laboratories Ltd Announces Standalone Unaudited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2019	20-02-14	CI
Kamron Laboratories Ltd Announces Unaudited Standalone Earnings Results for the Second Quarter and Half Year Ended September 30, 2019	19-11-14	CI
Kamron Laboratories Ltd. Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2019	19-08-19	CI
Kamron Laboratories Ltd. Reports Unaudited Standalone Earnings for the Fourth Quarter and Year Ended March 31, 2019	19-06-10	CI
Kamron Laboratories Ltd Appoints Bhavasthi R. Mehta as Company Secretary and Compliance Officer	19-02-14	CI

Adline Chem Lab Limited, formerly Kamron Laboratories Limited, is an India-based pharmaceutical company. The Company is operating in one segment: pharmaceutical products. The Company's products for the domestic market include anti-infectives, bone health, gastroenterology care, hemostatic, multi-vitamins, pediatric care, pain and inflammation, pregnancy and reproductive care, respiratory care and hepatocare. The Company's products for the international market include tablets, capsules and injections. The Company's veterinary products include B Complex Liver Extract With Vitamin B12 Inection, Chlorpheniramine Injection IP, Triflupromazine Hydrochloride Injection IP, Triamcinolone Acctonide Injection IP, Triamcinolone Acetonide IP and Tetracyclin-bolus Tablets. The Companyâs educational supplements include Demo-Dose Dyaz, Demo-dose colac, Demo-Dose Dilat and Demo-Eose eryth.

Sector

Pharmaceuticals

Calendar

2024-08-12 - Q1 2025 Earnings Release (Projected)

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
ADLINE CHEM LAB LIMITED	-51.03%	876K
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.76%	43.59B
OTSUKA HOLDINGS CO., LTD.	+28.00%	22.54B
SANDOZ GROUP AG	+20.25%	15.73B
CIPLA LIMITED	+18.82%	14.33B
ZYDUS LIFESCIENCES LIMITED	+55.83%	12.75B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-12.70%	6.48B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.65%	5.67B

Generic Pharmaceuticals

Adline Chem Lab Limited

Equities

KAMRLAB

INE276T01018

Pharmaceuticals

Kamron Laboratories Ltd Appoints Devarshi D. Patel as an Independent Director of the Company

Latest news about Adline Chem Lab Limited

Chart Adline Chem Lab Limited

Company Profile

Sector Generic Pharmaceuticals